ghk-cu human clinical trial hair growth Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application GHK-Cu Dosage and Protocol: A

Gramer, Gwendolyn et al

Clinical Benefits: Supports red blood cell formation and helps prevent megaloblastic anaemia Essential for neurological function and nerve tissue health Plays a key role in DNA synthesis and cell metabolism Supports cognitive function, concentration, and mood regulation Assists in the conversion of homocysteine, supporting cardiovascular health Helps address fatigue and weakness associated with B12 deficiency For patients presenting with deficiency, a loading protocol is typically recommended: weekly injections for three weeks, followed by monthly injections for three months, then a maintenance injection every three months

Beyond visual checks, the most reliable indicator is efficacy, if appetite suppression diminishes or weight loss stalls unexpectedly mid-protocol, a degraded vial is a possible cause

The Pernicious Anaemia Society notes this is well recognised but not fully understood

Visible particles: Do not inject